HAE:NYSE
Haemonetics Scandinavia Ab
103,52 USD
0,00%
(0,00) 1 D
6. okt., 16:00:03 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for HAE …
Markedsverdi
4,71 mrd.
Snittvolum
572,37k
Volum
97,00
P/E-forhold
50,49
52 u høy
110,45 USD
52 u lav
48,17 USD
EPS
2,05 USD
Beta
0,61
Utestående aksjer
45,50 mill.
Antall ansatte
3k
Markedsverdi
4,71 mrd.
Snittvolum
572,37k
Volum
97,00
P/E-forhold
50,49
52 u høy
110,45 USD
52 u lav
48,17 USD
EPS
2,05 USD
Beta
0,61
Utestående aksjer
45,50 mill.
Antall ansatte
3k
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 12 timer siden
Haemonetics stock heads toward its November 5 results
Zacks
·
for 1 døgn siden
PAHC vs. HAE: Which Stock Is the Better Value Option?
Benzinga
·
for 2 døgn siden
Haemonetics Q1 2027 Earnings Call Transcript
AD HOC NEWS
·
for 2 døgn siden
Haemonetics stock heads into November 5 results with key benchmarks
Profil
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
Om Haemonetics Scandinavia Ab
Administrerende direktørChristopher Simon
Ansatte3,01k
Grunnlagt1971
HovedkontorBoston, Massachusetts, USA
Sektor-
Nettstedhaemonetics.com